Menassie Taddese reports a stock award at XERS
By AlphaYouPublished Form 4
Taddese Menassie
Reporting filer
Menassie Taddese reports a stock award, not an open-market purchase or sale, in Xeris Biopharma Holdings, Inc.. Form 4 filed Nov 4, 2026 lists 2 entries.
- Disclosed
- Nov 4, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Taddese Menassie | 2026-11-02 | A | Grant or award | 22365 | 0 | 22,365 | 2 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Taddese Menassie | 2026-11-02 | A | Grant or award | 31499 | 10.17 | 31,499 | 2 days | Filed terms
|
Common Stock
- Owner
- Taddese Menassie
- Date
- 2026-11-02
- Code
- A
- Action
- Grant or award
- Quantity
- 22365
- Price
- 0
- Following holdings
- 22,365
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 22365
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 22365
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Taddese Menassie
- Date
- 2026-11-02
- Code
- A
- Action
- Grant or award
- Quantity
- 31499
- Price
- 10.17
- Following holdings
- 31,499
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 10.17
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 31499
- transaction Price Per Share: 10.17
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2036-11-02
- underlying Security Title: Common Stock
- underlying Security Shares: 31499
- shares Owned Following Transaction: 31499
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Taddese Menassie: Director.
- F1: These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the "Plan"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date.
- F2: These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.